Skip to main content
Clinical Trials/CTRI/2015/09/006213
CTRI/2015/09/006213
Completed
Phase 4

Comparative Evaluation of Hydroxyapatite and Bioactive glass In the Treatment of 3-Wall Intrabony Defects in Chronic Periodontitis: A Multicentric Randomized Controlled Clinical Trial

I0 sites84 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
I
Enrollment
84
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • 11The inclusion criteria included the presence of Systemically Healthy patients with Chronic periodontis requiring surgery with 3\-wall Intra bony defect \>3 mm deep (distance between alveolar crest and base of the defect on an intraoral periapical radiograph \[IOPA]) and a defect angle \>37 ͦ , along with an inter proximal probing depth (PD) \>5 mm after Phase I therapy (scaling and root planing \[SRP]) in asymptomatic teeth

Exclusion Criteria

  • Those having unacceptable oral hygiene (plaque index \[PI] 12 \>1\.5\) after reevaluation of Phase I therapy were also excluded from the study. In addition, teeth with furcation defects or nonvitality and/or mobility of at least grade II were also excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials